Sumitomo Pharma Co., Ltd.
SMDPY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4 | $348 | $264 | $256 |
| - Cash | $0 | $20 | $23 | $85 |
| + Debt | $2 | $309 | $305 | $374 |
| Enterprise Value | $6 | $637 | $546 | $545 |
| Revenue | $1 | $108 | $106 | $112 |
| % Growth | -99.3% | 2.2% | -6% | – |
| Gross Profit | $0 | $64 | $66 | $71 |
| % Margin | 61.7% | 59.2% | 62.5% | 63.1% |
| EBITDA | $1 | $26 | $6 | $27 |
| % Margin | 72.3% | 24.3% | 5.3% | 24.4% |
| Net Income | $1 | $11 | $2 | $53 |
| % Margin | 73.6% | 10.4% | 2.3% | 47.5% |
| EPS Diluted | 1.5 | 28.21 | 6.08 | 134.53 |
| % Growth | -94.7% | 364% | -95.5% | – |
| Operating Cash Flow | $0 | -$0 | $11 | $1 |
| Capital Expenditures | -$0 | -$1 | -$2 | -$2 |
| Free Cash Flow | $0 | -$2 | $9 | -$1 |